By Chloé Scordel, Communication Manager at R2D2-MH
Institut Pasteur coordinates R2D2-MH, a 5-year project with European Commission funding and dedicated project management support from the Grants Office. The project aims to identify risk and resilience factors associated with neurodevelopmental diversity, including Autism, ADHD or Intellectual Disability. The consortium is coordinated by Prof. Thomas Bourgeron and brings together 27 partners distributed worldwide who recently met in person for the annual General Assembly of the project.
R2D2-MH General Assembly meeting took place in Budapest on November 18-20, 2024, bringing together researchers, cocreation members, advocacy groups, clinicians, and healthcare professionals to advance the project’s goals.
With more than 80 participants, the meeting highlighted the power of collaboration: researchers shared work-package updates, while cocreation members emphasized the importance of integrating real-world needs in research projects. The participation of neurodivergent people, family members, advocacy groups and healthcare professionals ensured the representation and involvement of key stakeholders.
Thanks to our keynote sessions, we learned more about outcome measures in Neurodiversity and how they can be defined in the frame of R2D2-MH. In a dedicated group work, we also started to work on the sustainability strategy for the key innovations, necessary for a successful uptake of project outcomes in the real-world.
The insights and connections made during the event will guide the next steps of the R2D2-MH project, ensuring it continues to drive innovation in the field of Mental Health and Neurodiversity.
Comments